Email
IZ Express #1,693: CDC releases new interim VISs for HepB and PCV; COVID-19 public health emergency ends; and more
| From | Immunize.org <[email protected]> |
| Subject | IZ Express #1,693: CDC releases new interim VISs for HepB and PCV; COVID-19 public health emergency ends; and more |
| Date | May 17, 2023 10:45 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed]
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,693: May 17, 2023
Top Stories
* CDC releases new interim VISs for hepatitis B and pneumococcal conjugate vaccines
* The COVID-19 Public Health Emergency ended May 11. For now, there are few changes for vaccination providers.
* Immunize.org updates its “Vaccines: COVID-19” main page to reflect recent CDC and FDA changes, expiry of remaining Janssen product
* Spotlight: Immunize.org’s “Standing Orders Templates for Administering Vaccines” main page helps you simplify your vaccination practice
* Vaccines in the news
Immunize.org Pages and Handouts
* Immunize.org updates "You Must Provide Patients with Vaccine Information Statements (VISs) – It's Federal Law!" and "Dates of Current Vaccine Information Statements (VISs)"
* Correction: Immunize.org’s Chinese translation of “After the Shots…What to Do If Your Child Has Discomfort” dated 3/29/2023 removed to correct error. Use new version.
Featured Resources
* Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
* While supplies last! Laminated versions of CDC’s 2023 immunization schedules still available.
Notable Publications
* "Progress toward Poliomyelitis Eradication—Worldwide, January 2021–March 2023" published in MMWR
Global News
* IVAC updates its VIEW-hub, an interactive platform to visualize vaccine use around the world
Upcoming Events
* On-Demand: American College Health Association completes posting of its five-part webinar series, Facts or Fakes? Promoting Health Literacy Skills with Your Students; CE available
------------------------------------------------------------
Top Stories
------------------------------------------------------------
CDC releases new interim VISs for hepatitis B and pneumococcal conjugate vaccines
Immunize.org posted two new interim VISs, published by CDC. The hepatitis B vaccine VIS reflects the 2022 ACIP recommendation for catch-up hepatitis B vaccination of all people younger than age 60 years and the option to catch up those age 60 and older. The pneumococcal conjugate VIS incorporates newer pneumococcal conjugate vaccines (PCV15 and PCV20).
Immunize.org has updated its reference documents related to the use of VISs, You Must Provide Patients with Vaccine Information Statements (VISs) – It's Federal Law! ([link removed]) and Dates of Current Vaccine Information Statements (VISs) ([link removed]), with the publication dates of these new VISs.
* Hepatitis B Vaccine VIS ([link removed]) dated May 12, 2023
* Pneumococcal Conjugate (PCV) VIS ([link removed]) dated May 12, 2023
Related Links
* Immunize.org: Hepatitis B Vaccine VIS ([link removed]) main page
* Immunize.org: Hepatitis B Vaccine VIS ([link removed]) (PDF, English)
* Immunize.org: Pneumococcal Conjugate (PCV) VIS ([link removed]) main page
* Immunize.org: Pneumococcal Conjugate (PCV) VIS ([link removed]) (PDF, English)
* Immunize.org: VIS main page ([link removed]) with VISs in up to 47 languages ([link removed])
* CDC: What's New with VISs ([link removed]) main page
* CDC: Current VISs ([link removed]) main page
------------------------------------------------------------
The COVID-19 Public Health Emergency ended May 11. For now, there are few changes for vaccination providers.
On May 11, 2023, the U.S. Department of Health and Human Services (HHS) ended the federal Public Health Emergency (PHE) for COVID-19 ([link removed]), declared under Section 319 of the Public Health Service (PHS) Act. During the course of this emergency, 270 million Americans received nearly 700 million doses of COVID-19 vaccines.
At the end of the COVID-19 PHE on May 11, Americans will continue to be able to access COVID-19 vaccines at no cost, just as they have during the COVID-19 PHE, due to the requirements of the CDC COVID-19 Vaccination Program Provider Agreement. People will also continue to be able to access COVID-19 treatments just as they have during the COVID-19 PHE.
HHS has announced its plan to create the Bridge Access Program for COVID-19 Vaccines and Treatments Program ([link removed]) in coming months to ensure access to COVID-19 vaccines for uninsured Americans once federally purchased vaccines and treatment are no longer available. The program is intended to help maintain access to COVID-19 care for uninsured people at their local pharmacies, through existing public health sites, and at their local health centers.
The end of the PHE does not alter the FDA’s emergency use authorizations (EUAs) for COVID-19 products, including vaccines. In addition, certain liability protections extended to vaccination providers under the Public Readiness and Emergency Preparedness (PREP) Act have been extended. Those who regularly use surveillance data on COVID-19 from CDC will see significant changes to the data reported because certain types of data were only available under the PHE. CDC will also update available data less frequently.
Additional details and links to resource documents, including more information about COVID-19 testing and treatments, appear in the HHS Fact Sheet on the end of the COVID-19 PHE ([link removed]).
Related Links
* HHS Fact Sheet: End of the COVID-19 Public Health Emergency ([link removed]) (5/9/23)
* HHS Press Release: HHS Secretary Xavier Becerra Statement on End of the COVID-19 Public Health Emergency ([link removed]) (5/11/23)
* HHS web page: COVID-19 Public Health Emergency (PHE) ([link removed]) (5/10/23)
* HHS Fact Sheet: HHS Announces ‘HHS Bridge Access Program for COVID-19 Vaccines and Treatments’ to Maintain Access to COVID-19 Care for the Uninsured ([link removed]) (4/18/23)
------------------------------------------------------------
Immunize.org updates its “Vaccines: COVID-19” main page to reflect recent CDC and FDA changes, expiry of remaining Janssen product
Immunize.org updated its Vaccines: COVID-19 ([link removed]) main page. The updates reflect the removal of authorization for monovalent mRNA vaccines and removes references to the Janssen COVID-19 Vaccine (Johnson & Johnson), which is no longer available in the United States. The page contains updated links to the FDA Emergency Use Authorization (EUA) Fact Sheets for bivalent mRNA vaccines. The web page continues to direct visitors seeking quick links to all print-ready federal fact sheets and COVID-19 vaccination resources to Immunize.org’s Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]), which is updated at least monthly. The web page also continues to link to other important government and partner websites.
Bookmark Immunize.org's Vaccines: COVID-19 ([link removed]) main page to connect with a comprehensive list of resources from CDC and FDA including fact sheets, clinical considerations, vaccine administration tools, and storage and handling guidance.
Related Links
* Immunize.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize.org: Vaccines: COVID-19 ([link removed]) main page
* Immunize.org: Ask the Experts: COVID-19 ([link removed]) web page
* CDC: Interim Clinical Considerations ([link removed]) main page summarizing use of COVID-19 vaccines in the United States
------------------------------------------------------------
Spotlight: Immunize.org’s “Standing Orders Templates for Administering Vaccines” main page helps you simplify your vaccination practice
Immunize.org’s Standing Orders Templates for Administering Vaccines ([link removed]) main page includes 46 straightforward standing order templates that allow qualified healthcare professionals to assess the need for and administer vaccines to patients meeting certain criteria, such as age or underlying medical condition. In addition to templates developed by Immunize.org, the page includes links to CDC’s standing orders templates for all COVID-19 vaccines and all age groups, as well as CDC's standing orders template for mpox vaccination with Jynneos (Bavarian Nordic).
Standing orders help you increase vaccination rates by enabling assessment and vaccination of the patient without the need for clinician examination or a direct order from the attending provider at the time of the interaction. Standing orders can be established for the administration of one or more specific vaccines to a broad or narrow set of patients in healthcare settings such as clinics, hospitals, pharmacies, and long-term care facilities.
Visit the Standing Orders Templates for Administering Vaccines ([link removed]) main page on Immunize.org to view the standing orders templates.
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* New York Times: We Worked on the U.S. Pandemic Response. Here Are 13 Takeaways for the Next Health Emergency ([link removed]) (5/11/23)
* Chronicle of Philanthropy: The End of the COVID Health Emergency Must Not Spell the End of Progress toward Health Equity ([link removed]) (5/10/23)
* NBC: Rise of Mpox Cases in Chicago Raises Concern about Possible Summer Spread ([link removed]) (5/8/23)
* The Hill: First Measles Case Reported in Maine since 2019 ([link removed]) (5/8/23)
------------------------------------------------------------
Immunize.org Pages and Handouts
------------------------------------------------------------
Immunize.org updates "You Must Provide Patients with Vaccine Information Statements (VISs) – It's Federal Law!" and "Dates of Current Vaccine Information Statements (VISs)"
As noted in our top stories, Immunize.org updated two provider resources with the publication date of the revised Hepatitis B Vaccine ([link removed]) and Pneumococcal Conjugate (PCV) ([link removed]) VISs.
* You Must Provide Patients with Vaccine Information Statements (VISs) – It's Federal Law! ([link removed]) (2 pages)
* Dates of Current Vaccine Information Statements (VISs) ([link removed])
Related Links
* Immunize.org: Vaccine Information Statements ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Correction: Immunize.org’s Chinese translation of “After the Shots…What to Do If Your Child Has Discomfort” dated 3/29/2023 removed to correct error. Use new version.
Immunize.org was notified on May 10 to the presence of an error in the 3/29/2023 version of the Chinese translation of Immunize.org’s popular handout, After the Shots…What to Do If Your Child Has Discomfort ([link removed]). The version was immediately taken down from our website for correction by the translation service used by Immunize.org. Those who downloaded the Chinese version should discard it and replace it with the May 2023 version. The corrected translation will be posted on Immunize.org's Handouts: Chinese Translations ([link removed]) main page and will be announced in IZ Express. Immunize.org is grateful to the alert reader who notified us of the mistranslation.
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
Download Immunize.org’s free 142-page book on adult vaccination to help build your program and train your team: Vaccinating Adults: A Step-by-Step Guide (Guide) ([link removed]).
This thorough "how to" guide on adult vaccination provides easy-to-use, practical information covering all essential activities. It helps vaccine providers enhance their existing adult vaccination services or introduce them into any clinical setting.
The Guide is available to download/print either by chapter or in its entirety free at www.immunize.org/guide ([link removed]). The National Vaccine Program Office and CDC both supported the development of the Guide and provided early technical review.
The Guide is a valuable resource to assist providers in increasing adult vaccination rates. Be sure to get a copy today!
Please note: this guide was produced in 2017, before the COVID-19 era, and reflects the recommendations of that time.
Related Links
* Vaccinating Adults: A Step-by-Step Guide ([link removed]) main page, permitting download of entire Guide (142 pages, PDF) ([link removed])
* View the table of contents and individual chapters (PDF):
+ Table of Contents ([link removed])
+ Step 1: Getting Started ([link removed])
+ Step 2: Setting Up for Vaccination Services ([link removed])
+ Step 3: Vaccine Storage and Handling ([link removed])
+ Step 4: Deciding Whom to Vaccinate ([link removed])
+ Step 5: Administering Vaccines ([link removed])
+ Step 6: Documentation and Related Issues ([link removed])
+ Step 7A: Financial Considerations ([link removed])
+ Step 7B: How to Bill for Adult Immunizations ([link removed])
* Immunize.org’s educational materials (handouts) on adult immunization ([link removed])
------------------------------------------------------------
While supplies last! Laminated versions of CDC’s 2023 immunization schedules still available.
Immunize.org's laminated versions of the 2023 U.S. child and adolescent immunization schedule ([link removed]) and the 2023 U.S. adult immunization schedule ([link removed]) are still available. Order while supplies last. Once sold out, we will not print more until 2024.
While the schedules are available online from CDC at no cost, Immunize.org’s laminated schedules are ideal for use in any busy healthcare setting. Their tough coating can be wiped down, and they’re durable enough to stand up to a year of use.
* Length: Each schedule with appendices is 12 pages
* Size: Standard 8.5” X 11” booklet format
* Full Color: With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes
* Bonus: The adult schedule includes Immunize.org’s popular 1-page handout summarizing the dose, route, and needle length recommendations for all vaccines and recipients
Pricing for Each Schedule
$10.00: 1 copy
$ 9.50 each: 2–4 copies
$ 8.50 each: 5–19 copies
$ 7.50 each: 20–99 copies
$ 6.00 each: 100–499 copies
$ 5.00 each: 500–999 copies
$ 4.00 each: 1,000–1,999 copies
$ 3.25 each: 2,000+ copies
Visit Shop Immunize.org: Laminated Schedules ([link removed]) to view images of each page and order today!
For additional information, call 651-647-9009 or email [email protected].
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
* CDC: Immunization Schedules ([link removed])
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
"Progress toward Poliomyelitis Eradication—Worldwide, January 2021–March 2023" published in MMWR
CDC published Progress toward Poliomyelitis Eradication—Worldwide, January 2021–March 2023 ([link removed]) on May 12 in MMWR ([link removed]). A portion of the summary appears below.
Endemic transmission of wild poliovirus type 1 (WPV1) continues only in Afghanistan and Pakistan. . . .
In 2022, Malawi and Mozambique reported WPV1 cases linked to a Pakistan strain, the first WPV1 cases in the African region since 2016. During 2022 and 2023, Afghanistan and Pakistan reported WPV1 cases. Circulating vaccine-derived polioviruses were detected in areas of the world where poliovirus had been eliminated. Cocirculation of more than one poliovirus type occurred in multiple countries. . . .
The detections of poliovirus in areas where it had been previously eliminated underscore the threat of continued poliovirus spread to any area where the population is insufficiently vaccinated against poliovirus.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
Global News
------------------------------------------------------------
IVAC updates its VIEW-hub, an interactive platform to visualize vaccine use around the world
The Johns Hopkins University International Vaccine Access Center ([link removed]) (IVAC) updated its VIEW-hub, a map-based platform ([link removed]) for visualizing data on vaccine use, impact, and coverage status globally and in the 73 countries receiving vaccines from Gavi. In addition to data on human papillomavirus, typhoid conjugate, pneumococcal conjugate, rotavirus, Haemophilus, and inactivated polio vaccines, VIEW-hub now includes COVID-19 Vaccines Briefs, including effectiveness in children.
Explore the interactive maps here. ([link removed])
Related Link
* VIEW-hub website ([link removed])
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
On-Demand: American College Health Association completes posting of its five-part webinar series, Facts or Fakes? Promoting Health Literacy Skills with Your Students; CE available
The American College Health Association (ACHA) offered a free, five-part webinar series, Facts or Fakes? Promoting Health Literacy Skills with Your Students ([link removed]). This five-part webinar series provides tools to help students and others navigate misinformation, disinformation, and the infodemic. Webinars include:
* January 10 – "Health Literacy 101" (available on-demand ([link removed]) )
* February 21 – "Digital Wellbeing and Mental Health: Helping Me Is Helping We" (available on-demand ([link removed]) )
* March 7 – "Debunking Fake News" (available on-demand ([link removed]) )
* April 18 – "Confronting Misinformation in Our Circles of Influence" (available on-demand ([link removed]) )
* May 9 – "Managing the Infodemic: Getting Started" (available on-demand ([link removed]) )
Up to 5 hours of credit are available for CNE, CME, and CHES, and 1 CE is available for counselors for session 2.
Register for the free webinars ([link removed]).
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
[link removed]
[link removed]
[link removed] [link removed]
Email not displaying correctly? View it in your browser ([link removed]).
[link removed]
Issue 1,693: May 17, 2023
Top Stories
* CDC releases new interim VISs for hepatitis B and pneumococcal conjugate vaccines
* The COVID-19 Public Health Emergency ended May 11. For now, there are few changes for vaccination providers.
* Immunize.org updates its “Vaccines: COVID-19” main page to reflect recent CDC and FDA changes, expiry of remaining Janssen product
* Spotlight: Immunize.org’s “Standing Orders Templates for Administering Vaccines” main page helps you simplify your vaccination practice
* Vaccines in the news
Immunize.org Pages and Handouts
* Immunize.org updates "You Must Provide Patients with Vaccine Information Statements (VISs) – It's Federal Law!" and "Dates of Current Vaccine Information Statements (VISs)"
* Correction: Immunize.org’s Chinese translation of “After the Shots…What to Do If Your Child Has Discomfort” dated 3/29/2023 removed to correct error. Use new version.
Featured Resources
* Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
* While supplies last! Laminated versions of CDC’s 2023 immunization schedules still available.
Notable Publications
* "Progress toward Poliomyelitis Eradication—Worldwide, January 2021–March 2023" published in MMWR
Global News
* IVAC updates its VIEW-hub, an interactive platform to visualize vaccine use around the world
Upcoming Events
* On-Demand: American College Health Association completes posting of its five-part webinar series, Facts or Fakes? Promoting Health Literacy Skills with Your Students; CE available
------------------------------------------------------------
Top Stories
------------------------------------------------------------
CDC releases new interim VISs for hepatitis B and pneumococcal conjugate vaccines
Immunize.org posted two new interim VISs, published by CDC. The hepatitis B vaccine VIS reflects the 2022 ACIP recommendation for catch-up hepatitis B vaccination of all people younger than age 60 years and the option to catch up those age 60 and older. The pneumococcal conjugate VIS incorporates newer pneumococcal conjugate vaccines (PCV15 and PCV20).
Immunize.org has updated its reference documents related to the use of VISs, You Must Provide Patients with Vaccine Information Statements (VISs) – It's Federal Law! ([link removed]) and Dates of Current Vaccine Information Statements (VISs) ([link removed]), with the publication dates of these new VISs.
* Hepatitis B Vaccine VIS ([link removed]) dated May 12, 2023
* Pneumococcal Conjugate (PCV) VIS ([link removed]) dated May 12, 2023
Related Links
* Immunize.org: Hepatitis B Vaccine VIS ([link removed]) main page
* Immunize.org: Hepatitis B Vaccine VIS ([link removed]) (PDF, English)
* Immunize.org: Pneumococcal Conjugate (PCV) VIS ([link removed]) main page
* Immunize.org: Pneumococcal Conjugate (PCV) VIS ([link removed]) (PDF, English)
* Immunize.org: VIS main page ([link removed]) with VISs in up to 47 languages ([link removed])
* CDC: What's New with VISs ([link removed]) main page
* CDC: Current VISs ([link removed]) main page
------------------------------------------------------------
The COVID-19 Public Health Emergency ended May 11. For now, there are few changes for vaccination providers.
On May 11, 2023, the U.S. Department of Health and Human Services (HHS) ended the federal Public Health Emergency (PHE) for COVID-19 ([link removed]), declared under Section 319 of the Public Health Service (PHS) Act. During the course of this emergency, 270 million Americans received nearly 700 million doses of COVID-19 vaccines.
At the end of the COVID-19 PHE on May 11, Americans will continue to be able to access COVID-19 vaccines at no cost, just as they have during the COVID-19 PHE, due to the requirements of the CDC COVID-19 Vaccination Program Provider Agreement. People will also continue to be able to access COVID-19 treatments just as they have during the COVID-19 PHE.
HHS has announced its plan to create the Bridge Access Program for COVID-19 Vaccines and Treatments Program ([link removed]) in coming months to ensure access to COVID-19 vaccines for uninsured Americans once federally purchased vaccines and treatment are no longer available. The program is intended to help maintain access to COVID-19 care for uninsured people at their local pharmacies, through existing public health sites, and at their local health centers.
The end of the PHE does not alter the FDA’s emergency use authorizations (EUAs) for COVID-19 products, including vaccines. In addition, certain liability protections extended to vaccination providers under the Public Readiness and Emergency Preparedness (PREP) Act have been extended. Those who regularly use surveillance data on COVID-19 from CDC will see significant changes to the data reported because certain types of data were only available under the PHE. CDC will also update available data less frequently.
Additional details and links to resource documents, including more information about COVID-19 testing and treatments, appear in the HHS Fact Sheet on the end of the COVID-19 PHE ([link removed]).
Related Links
* HHS Fact Sheet: End of the COVID-19 Public Health Emergency ([link removed]) (5/9/23)
* HHS Press Release: HHS Secretary Xavier Becerra Statement on End of the COVID-19 Public Health Emergency ([link removed]) (5/11/23)
* HHS web page: COVID-19 Public Health Emergency (PHE) ([link removed]) (5/10/23)
* HHS Fact Sheet: HHS Announces ‘HHS Bridge Access Program for COVID-19 Vaccines and Treatments’ to Maintain Access to COVID-19 Care for the Uninsured ([link removed]) (4/18/23)
------------------------------------------------------------
Immunize.org updates its “Vaccines: COVID-19” main page to reflect recent CDC and FDA changes, expiry of remaining Janssen product
Immunize.org updated its Vaccines: COVID-19 ([link removed]) main page. The updates reflect the removal of authorization for monovalent mRNA vaccines and removes references to the Janssen COVID-19 Vaccine (Johnson & Johnson), which is no longer available in the United States. The page contains updated links to the FDA Emergency Use Authorization (EUA) Fact Sheets for bivalent mRNA vaccines. The web page continues to direct visitors seeking quick links to all print-ready federal fact sheets and COVID-19 vaccination resources to Immunize.org’s Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]), which is updated at least monthly. The web page also continues to link to other important government and partner websites.
Bookmark Immunize.org's Vaccines: COVID-19 ([link removed]) main page to connect with a comprehensive list of resources from CDC and FDA including fact sheets, clinical considerations, vaccine administration tools, and storage and handling guidance.
Related Links
* Immunize.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize.org: Vaccines: COVID-19 ([link removed]) main page
* Immunize.org: Ask the Experts: COVID-19 ([link removed]) web page
* CDC: Interim Clinical Considerations ([link removed]) main page summarizing use of COVID-19 vaccines in the United States
------------------------------------------------------------
Spotlight: Immunize.org’s “Standing Orders Templates for Administering Vaccines” main page helps you simplify your vaccination practice
Immunize.org’s Standing Orders Templates for Administering Vaccines ([link removed]) main page includes 46 straightforward standing order templates that allow qualified healthcare professionals to assess the need for and administer vaccines to patients meeting certain criteria, such as age or underlying medical condition. In addition to templates developed by Immunize.org, the page includes links to CDC’s standing orders templates for all COVID-19 vaccines and all age groups, as well as CDC's standing orders template for mpox vaccination with Jynneos (Bavarian Nordic).
Standing orders help you increase vaccination rates by enabling assessment and vaccination of the patient without the need for clinician examination or a direct order from the attending provider at the time of the interaction. Standing orders can be established for the administration of one or more specific vaccines to a broad or narrow set of patients in healthcare settings such as clinics, hospitals, pharmacies, and long-term care facilities.
Visit the Standing Orders Templates for Administering Vaccines ([link removed]) main page on Immunize.org to view the standing orders templates.
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* New York Times: We Worked on the U.S. Pandemic Response. Here Are 13 Takeaways for the Next Health Emergency ([link removed]) (5/11/23)
* Chronicle of Philanthropy: The End of the COVID Health Emergency Must Not Spell the End of Progress toward Health Equity ([link removed]) (5/10/23)
* NBC: Rise of Mpox Cases in Chicago Raises Concern about Possible Summer Spread ([link removed]) (5/8/23)
* The Hill: First Measles Case Reported in Maine since 2019 ([link removed]) (5/8/23)
------------------------------------------------------------
Immunize.org Pages and Handouts
------------------------------------------------------------
Immunize.org updates "You Must Provide Patients with Vaccine Information Statements (VISs) – It's Federal Law!" and "Dates of Current Vaccine Information Statements (VISs)"
As noted in our top stories, Immunize.org updated two provider resources with the publication date of the revised Hepatitis B Vaccine ([link removed]) and Pneumococcal Conjugate (PCV) ([link removed]) VISs.
* You Must Provide Patients with Vaccine Information Statements (VISs) – It's Federal Law! ([link removed]) (2 pages)
* Dates of Current Vaccine Information Statements (VISs) ([link removed])
Related Links
* Immunize.org: Vaccine Information Statements ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* Immunize.org: Handouts for Patients and Staff ([link removed]) main page, where you can sort materials by topic, vaccine, or language
* Immunize.org: Educational Materials for Patients and Staff ([link removed])—an alphabetical listing of more than 230 ready-to-print staff educational materials and patient handouts
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
------------------------------------------------------------
Correction: Immunize.org’s Chinese translation of “After the Shots…What to Do If Your Child Has Discomfort” dated 3/29/2023 removed to correct error. Use new version.
Immunize.org was notified on May 10 to the presence of an error in the 3/29/2023 version of the Chinese translation of Immunize.org’s popular handout, After the Shots…What to Do If Your Child Has Discomfort ([link removed]). The version was immediately taken down from our website for correction by the translation service used by Immunize.org. Those who downloaded the Chinese version should discard it and replace it with the May 2023 version. The corrected translation will be posted on Immunize.org's Handouts: Chinese Translations ([link removed]) main page and will be announced in IZ Express. Immunize.org is grateful to the alert reader who notified us of the mistranslation.
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Organizing a new vaccination program? Use Immunize.org’s Vaccinating Adults: A Step-by-Step Guide—free to download by chapter or in its entirety.
Download Immunize.org’s free 142-page book on adult vaccination to help build your program and train your team: Vaccinating Adults: A Step-by-Step Guide (Guide) ([link removed]).
This thorough "how to" guide on adult vaccination provides easy-to-use, practical information covering all essential activities. It helps vaccine providers enhance their existing adult vaccination services or introduce them into any clinical setting.
The Guide is available to download/print either by chapter or in its entirety free at www.immunize.org/guide ([link removed]). The National Vaccine Program Office and CDC both supported the development of the Guide and provided early technical review.
The Guide is a valuable resource to assist providers in increasing adult vaccination rates. Be sure to get a copy today!
Please note: this guide was produced in 2017, before the COVID-19 era, and reflects the recommendations of that time.
Related Links
* Vaccinating Adults: A Step-by-Step Guide ([link removed]) main page, permitting download of entire Guide (142 pages, PDF) ([link removed])
* View the table of contents and individual chapters (PDF):
+ Table of Contents ([link removed])
+ Step 1: Getting Started ([link removed])
+ Step 2: Setting Up for Vaccination Services ([link removed])
+ Step 3: Vaccine Storage and Handling ([link removed])
+ Step 4: Deciding Whom to Vaccinate ([link removed])
+ Step 5: Administering Vaccines ([link removed])
+ Step 6: Documentation and Related Issues ([link removed])
+ Step 7A: Financial Considerations ([link removed])
+ Step 7B: How to Bill for Adult Immunizations ([link removed])
* Immunize.org’s educational materials (handouts) on adult immunization ([link removed])
------------------------------------------------------------
While supplies last! Laminated versions of CDC’s 2023 immunization schedules still available.
Immunize.org's laminated versions of the 2023 U.S. child and adolescent immunization schedule ([link removed]) and the 2023 U.S. adult immunization schedule ([link removed]) are still available. Order while supplies last. Once sold out, we will not print more until 2024.
While the schedules are available online from CDC at no cost, Immunize.org’s laminated schedules are ideal for use in any busy healthcare setting. Their tough coating can be wiped down, and they’re durable enough to stand up to a year of use.
* Length: Each schedule with appendices is 12 pages
* Size: Standard 8.5” X 11” booklet format
* Full Color: With color coding for easy reading, our laminated schedules replicate the original CDC formatting, including the essential tables and notes
* Bonus: The adult schedule includes Immunize.org’s popular 1-page handout summarizing the dose, route, and needle length recommendations for all vaccines and recipients
Pricing for Each Schedule
$10.00: 1 copy
$ 9.50 each: 2–4 copies
$ 8.50 each: 5–19 copies
$ 7.50 each: 20–99 copies
$ 6.00 each: 100–499 copies
$ 5.00 each: 500–999 copies
$ 4.00 each: 1,000–1,999 copies
$ 3.25 each: 2,000+ copies
Visit Shop Immunize.org: Laminated Schedules ([link removed]) to view images of each page and order today!
For additional information, call 651-647-9009 or email [email protected].
Related Links
* Immunize.org: Laminated Child and Adolescent Immunization Schedules (0–18 years) ([link removed]) web page
* Immunize.org: Laminated Adult Immunization Schedules (19 and older) ([link removed]) web page
* Immunize.org: Shop Immunize.org ([link removed]) main page
* CDC: Immunization Schedules ([link removed])
------------------------------------------------------------
Notable Publications
------------------------------------------------------------
"Progress toward Poliomyelitis Eradication—Worldwide, January 2021–March 2023" published in MMWR
CDC published Progress toward Poliomyelitis Eradication—Worldwide, January 2021–March 2023 ([link removed]) on May 12 in MMWR ([link removed]). A portion of the summary appears below.
Endemic transmission of wild poliovirus type 1 (WPV1) continues only in Afghanistan and Pakistan. . . .
In 2022, Malawi and Mozambique reported WPV1 cases linked to a Pakistan strain, the first WPV1 cases in the African region since 2016. During 2022 and 2023, Afghanistan and Pakistan reported WPV1 cases. Circulating vaccine-derived polioviruses were detected in areas of the world where poliovirus had been eliminated. Cocirculation of more than one poliovirus type occurred in multiple countries. . . .
The detections of poliovirus in areas where it had been previously eliminated underscore the threat of continued poliovirus spread to any area where the population is insufficiently vaccinated against poliovirus.
Access the MMWR article in HTML ([link removed]) or PDF ([link removed]).
Related Link
* MMWR's main page ([link removed]) provides access to MMWR Weekly and its companion publications
------------------------------------------------------------
Global News
------------------------------------------------------------
IVAC updates its VIEW-hub, an interactive platform to visualize vaccine use around the world
The Johns Hopkins University International Vaccine Access Center ([link removed]) (IVAC) updated its VIEW-hub, a map-based platform ([link removed]) for visualizing data on vaccine use, impact, and coverage status globally and in the 73 countries receiving vaccines from Gavi. In addition to data on human papillomavirus, typhoid conjugate, pneumococcal conjugate, rotavirus, Haemophilus, and inactivated polio vaccines, VIEW-hub now includes COVID-19 Vaccines Briefs, including effectiveness in children.
Explore the interactive maps here. ([link removed])
Related Link
* VIEW-hub website ([link removed])
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
On-Demand: American College Health Association completes posting of its five-part webinar series, Facts or Fakes? Promoting Health Literacy Skills with Your Students; CE available
The American College Health Association (ACHA) offered a free, five-part webinar series, Facts or Fakes? Promoting Health Literacy Skills with Your Students ([link removed]). This five-part webinar series provides tools to help students and others navigate misinformation, disinformation, and the infodemic. Webinars include:
* January 10 – "Health Literacy 101" (available on-demand ([link removed]) )
* February 21 – "Digital Wellbeing and Mental Health: Helping Me Is Helping We" (available on-demand ([link removed]) )
* March 7 – "Debunking Fake News" (available on-demand ([link removed]) )
* April 18 – "Confronting Misinformation in Our Circles of Influence" (available on-demand ([link removed]) )
* May 9 – "Managing the Infodemic: Getting Started" (available on-demand ([link removed]) )
Up to 5 hours of credit are available for CNE, CME, and CHES, and 1 CE is available for counselors for session 2.
Register for the free webinars ([link removed]).
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]).
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]).
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp